| Telaprevir for previously untreated chronic hepatitis C virus infection IM Jacobson, JG McHutchison, G Dusheiko, AM Di Bisceglie, KR Reddy, ... New England Journal of Medicine 364 (25), 2405-2416, 2011 | 3278 | 2011 |
| Telaprevir for retreatment of HCV infection S Zeuzem, P Andreone, S Pol, E Lawitz, M Diago, S Roberts, R Focaccia, ... New England Journal of Medicine 364 (25), 2417-2428, 2011 | 2117 | 2011 |
| Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B CL Lai, D Shouval, AS Lok, TT Chang, H Cheinquer, Z Goodman, ... New England Journal of Medicine 354 (10), 1011-1020, 2006 | 1683 | 2006 |
| Statements from the Taormina expert meeting on occult hepatitis B virus infection G Raimondo, JP Allain, MR Brunetto, MA Buendia, DS Chen, M Colombo, ... Journal of hepatology 49 (4), 652-657, 2008 | 1127 | 2008 |
| Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma: studies in percutaneous liver biopsies and post … DA Shafritz, D Shouval, HI Sherman, SJ Hadziyannis, MC Kew New England Journal of Medicine 305 (18), 1067-1073, 1981 | 882 | 1981 |
| EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B: 13–14 September, 2002 Geneva, Switzerland Consensus statement (Long version) TE Jury Journal of Hepatology 39, 3-25, 2003 | 698 | 2003 |
| A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children A Werzberger, B Mensch, B Kuter, L Brown, J Lewis, R Sitrin, W Miller, ... New England journal of medicine 327 (7), 453-457, 1992 | 667 | 1992 |
| p53 mutation in hepatocellular carcinoma after aflatoxin exposure B Bressac, A Puisieux, M Kew, M Volkmann, S Bozcall, JB Mura, ... The Lancet 338 (8779), 1356-1359, 1991 | 636 | 1991 |
| The global impact of vaccination against hepatitis B: a historical overview AR Zanetti, P Van Damme, D Shouval Vaccine 26 (49), 6266-6273, 2008 | 546 | 2008 |
| Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies G Lalazar, D Rund, D Shouval British journal of haematology 136 (5), 699-712, 2007 | 449 | 2007 |
| Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review D Shouval, D Samuel Hepatology 32 (6), 1189-1195, 2000 | 330 | 2000 |
| Incidence of hepatitis A in Israel following universal immunization of toddlers R Dagan, A Leventhal, E Anis, P Slater, Y Ashur, D Shouval Jama 294 (2), 202-210, 2005 | 329 | 2005 |
| Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention SM Lemon, JJ Ott, P Van Damme, D Shouval Journal of Hepatology 68 (1), 167-184, 2018 | 314 | 2018 |
| Relapsing hepatitis A review of 14 cases and literature survey M Glikson, E Galun, R Oren, R Tur-Kaspa, D Shouval Medicine 71 (1), 14-23, 1992 | 313 | 1992 |
| Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line PR Chakraborty, N Ruiz-Opazo, D Shouval, DA Shafritz Nature 286 (5772), 531-533, 1980 | 307 | 1980 |
| Hepatitis A booster vaccination: is there a need? P Van Damme, J Banatvala, O Fay, S Iwarson, B McMahon, K Van Herck, ... The lancet 362 (9389), 1065-1071, 2003 | 302 | 2003 |
| Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients RN Gunson, D Shouval, M Roggendorf, H Zaaijer, H Nicholas, ... Journal of Clinical Virology 27 (3), 213-230, 2003 | 280 | 2003 |
| Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor E Elinav, IZ Ben–Dov, Y Shapira, N Daudi, R Adler, D Shouval, ... Gastroenterology 130 (4), 1129-1134, 2006 | 218 | 2006 |
| Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers O Shibolet, Y Ilan, S Gillis, A Hubert, D Shouval, R Safadi Blood, The Journal of the American Society of Hematology 100 (2), 391-396, 2002 | 203 | 2002 |
| EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients M Cornberg, M Buti, CS Eberhardt, PA Grossi, D Shouval Journal of hepatology 74 (4), 944-951, 2021 | 201 | 2021 |
